LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 59

Search options

  1. Article: Poor knowledge and low coverage of hepatitis B vaccination among injecting drug users in Sydney.

    Day, Carolyn / White, Bethany / Ross, Joanne / Dolan, Kate

    Australian and New Zealand journal of public health

    2003  Volume 27, Issue 5, Page(s) 558

    MeSH term(s) Adult ; Australia/epidemiology ; Female ; HIV Seropositivity ; Health Knowledge, Attitudes, Practice ; Hepatitis B/epidemiology ; Hepatitis B/prevention & control ; Hepatitis C/epidemiology ; Hepatitis C/prevention & control ; Humans ; Male ; Risk-Taking ; Substance Abuse Treatment Centers ; Substance Abuse, Intravenous/complications ; Substance Abuse, Intravenous/psychology ; Substance Abuse, Intravenous/virology ; Vaccination/utilization
    Language English
    Publishing date 2003-10
    Publishing country Australia
    Document type Letter
    ZDB-ID 1323548-5
    ISSN 1326-0200
    ISSN 1326-0200
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Drug Interactions With Nirmatrelvir-Ritonavir in Older Adults Using Multiple Medications.

    Ross, Sydney B / Bortolussi-Courval, Émilie / Hanula, Ryan / Lee, Todd Campbell / Goodwin Wilson, Marnie / McDonald, Emily G

    JAMA network open

    2022  Volume 5, Issue 7, Page(s) e2220184

    MeSH term(s) Aged ; Drug Interactions ; Humans ; Ritonavir/therapeutic use
    Chemical Substances Ritonavir (O3J8G9O825)
    Language English
    Publishing date 2022-07-01
    Publishing country United States
    Document type Journal Article
    ISSN 2574-3805
    ISSN (online) 2574-3805
    DOI 10.1001/jamanetworkopen.2022.20184
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Nasal airway inflammatory responses and pathogen detection in infants with cystic fibrosis.

    Kopp, Benjamin T / Ross, Sydney E / Bojja, Dinesh / Guglani, Lokesh / Chandler, Joshua D / Tirouvanziam, Rabindra / Thompson, Misty / Slaven, James E / Chmiel, James F / Siracusa, Christopher / Sanders, Don B

    Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society

    2023  

    Abstract: Background: Detecting airway inflammation non-invasively in infants with cystic fibrosis (CF) is difficult. We hypothesized that markers of inflammation in CF [IL-1β, IL-6, IL-8, IL-10, IL-17A, neutrophil elastase (NE) and tumor necrosis factor (TNF-α)] ...

    Abstract Background: Detecting airway inflammation non-invasively in infants with cystic fibrosis (CF) is difficult. We hypothesized that markers of inflammation in CF [IL-1β, IL-6, IL-8, IL-10, IL-17A, neutrophil elastase (NE) and tumor necrosis factor (TNF-α)] could be measured in infants with CF from nasal fluid and would be elevated during viral infections or clinician-defined pulmonary exacerbations (PEx).
    Methods: We collected nasal fluid, nasal swabs, and hair samples from 34 infants with CF during monthly clinic visits, sick visits, and hospitalizations. Nasal fluid was isolated and analyzed for cytokines. Respiratory viral detection on nasal swabs was performed using the Luminex NxTAG® Respiratory Pathogen Panel. Hair samples were analyzed for nicotine concentration by reverse-phase high-performance liquid chromatography. We compared nasal cytokine concentrations between the presence and absence of detected respiratory viruses, PEx, and smoke exposure.
    Results: A total of 246 samples were analyzed. Compared to measurements in the absence of respiratory viruses, mean concentrations of IL-6, IL-8, TNF-α, and NE were significantly increased while IL-17A was significantly decreased in infants positive for respiratory viruses. IL-17A was significantly decreased and NE increased in those with a PEx. IL-8 and NE were significantly increased in infants with enteric pathogen positivity on airway cultures, but not P. aeruginosa or S. aureus. Compared to those with no smoke exposure, there were significantly higher levels of IL-6, IL-10, and NE in infants with detectable levels of nicotine.
    Conclusions: Noninvasive collection of nasal fluid may identify inflammation in infants with CF during changing clinical or environmental exposures.
    Language English
    Publishing date 2023-11-15
    Publishing country Netherlands
    Document type Journal Article
    ZDB-ID 2084724-5
    ISSN 1873-5010 ; 1569-1993
    ISSN (online) 1873-5010
    ISSN 1569-1993
    DOI 10.1016/j.jcf.2023.10.020
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Increased microbiota diversity associated with higher FEV

    Kloepfer, Kirsten M / Ross, Sydney E / Hemmerich, Christopher M / Slaven, James E / Rusch, Douglas B / Davis, Stephanie D

    Pediatric pulmonology

    2019  Volume 55, Issue 1, Page(s) 27–29

    Language English
    Publishing date 2019-11-05
    Publishing country United States
    Document type Letter
    ZDB-ID 632784-9
    ISSN 1099-0496 ; 8755-6863
    ISSN (online) 1099-0496
    ISSN 8755-6863
    DOI 10.1002/ppul.24559
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: Serious Cardiovascular Adverse Events Associated with Hydroxychloroquine/Chloroquine Alone or with Azithromycin in Patients with COVID-19: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS).

    Zhao, Ying / Zhang, Jingru / Zheng, Kai / Thai, Sydney / Simpson, Ross J / Kinlaw, Alan C / Xu, Yang / Wei, Jingkai / Cui, Xiangli / Buse, John B / Stürmer, Til / Wang, Tiansheng

    Drugs - real world outcomes

    2022  Volume 9, Issue 2, Page(s) 231–241

    Abstract: Background: The use of hydroxychloroquine or chloroquine (HCQ/CQ) as monotherapy or combined with azithromycin for the treatment of coronavirus disease 2019 (COVID-19) may increase the risk of serious cardiovascular adverse events (SCAEs).: Objective!# ...

    Abstract Background: The use of hydroxychloroquine or chloroquine (HCQ/CQ) as monotherapy or combined with azithromycin for the treatment of coronavirus disease 2019 (COVID-19) may increase the risk of serious cardiovascular adverse events (SCAEs).
    Objective: Our objective was to describe and evaluate the risk of SCAEs with HCQ/CQ as monotherapy or combined with azithromycin compared with that for therapeutic alternatives.
    Methods: We performed a disproportionality analysis and descriptive case series using the US FDA Adverse Event Reporting System.
    Results: Compared with remdesivir, HCQ/CQ was associated with increased reporting of SCAEs (reporting odds ratio [ROR] 2.1; 95% confidence interval [CI] 1.8-2.5), torsade de pointes (TdP)/QTc prolongation (ROR 35.4; 95% CI 19.4-64.5), and ventricular arrhythmia (ROR 2.5; 95% CI 1.6-3.9); similar results were found in comparison with other therapeutic alternatives. Compared with lopinavir/ritonavir, HCQ/CQ was associated with increased reporting of ventricular arrhythmia (ROR 10.5; 95% CI 3.3-33.4); RORs were larger when HCQ/CQ was used in combination with azithromycin. In 2020, 312 of the 575 reports of SCAEs listed concomitant use of HCQ/CQ and azithromycin, including QTc prolongation (61.4%), ventricular arrhythmia (12.0%), atrial fibrillation (8.2%), TdP (4.9%), and cardiac arrest (4.4%); 88 (15.3%) cases resulted in hospitalization and 79 (13.7%) resulted in death. In total, 122 fatal QTc prolongation-related cardiovascular reports were associated with 1.4 times higher odds of reported death than those induced by SCAEs; 87 patients received more than one QTc-prolonging agent.
    Conclusions: Patients treated with HCQ/CQ monotherapy or HCQ/CQ + azithromycin may be at increased risk of SCAEs, TdP/QTc prolongation, and ventricular arrhythmia. Cardiovascular risks need to be considered when evaluating the benefit/harm balance of treatment with HCQ/CQ, especially with the concurrent use of QTc-prolonging agents and cytochrome P450 3A4 inhibitors when treating COVID-19.
    Language English
    Publishing date 2022-04-06
    Publishing country Switzerland
    Document type Journal Article
    ZDB-ID 2806600-5
    ISSN 2198-9788 ; 2199-1154
    ISSN (online) 2198-9788
    ISSN 2199-1154
    DOI 10.1007/s40801-022-00300-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Adverse Drug Events in Older Adults: Review of Adjudication Methods in Deprescribing Studies.

    Ross MSc Candidate, Sydney B / Wu, Peter E / Atique Md Candidate, Anika / Papillon-Ferland, Louise / Tamblyn, Robyn / Lee, Todd C / McDonald, Emily G

    Journal of the American Geriatrics Society

    2020  Volume 68, Issue 7, Page(s) 1594–1602

    Abstract: Objectives: Polypharmacy is common in older adults and associated with adverse drug events (ADEs). Several methods have been described in studies to help correlate ADE causation. We performed a narrative review to identify methods for ADE adjudication. ... ...

    Abstract Objectives: Polypharmacy is common in older adults and associated with adverse drug events (ADEs). Several methods have been described in studies to help correlate ADE causation. We performed a narrative review to identify methods for ADE adjudication. We compared their strengths and limitations to assess their applicability to deprescribing studies (of which clinical trials are a subset) and to encourage the use of a standardized method in future studies.
    Design: We performed a review of original articles (1946-2019) using the Medline (Ovid) and Cochrane databases. We also conducted a manual reference search of review articles. Abstracts were screened for relevance.
    Measurements: Adjudication methods were compared for advantages and limitations including validity, ease of use, and applicability to clinical trials with deprescribing as the primary intervention.
    Results: The search yielded 1881 articles of which 175 articles were included for full-text review. Following in-depth review, 135 were excluded: 79 had no ADE outcome data, 35 were not specific to older adults, 9 were not relevant, 6 were review articles, 5 contained duplicate data, and 1 was not written in French or English. Forty articles remained for analysis, from which we identified 10 unique ADE adjudication methods. No method was developed originally for use in a deprescribing setting.
    Conclusion: A standard method to identify ADEs is important to capture the outcome reliably in deprescribing studies. All methods we identified had limitations in terms of capturing adverse events from the withdrawal of medications. Future work should focus on refining adjudication methods for capturing ADEs related not only to medication continuation and new drug starts but also to deprescribing and drug discontinuation. J Am Geriatr Soc 68:1594-1602, 2020.
    MeSH term(s) Deprescriptions ; Drug-Related Side Effects and Adverse Reactions ; Polypharmacy
    Language English
    Publishing date 2020-03-06
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.16382
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: In children, the microbiota of the nasopharynx and bronchoalveolar lavage fluid are both similar and different.

    Kloepfer, Kirsten M / Deschamp, Ashley R / Ross, Sydney E / Peterson-Carmichael, Stacey L / Hemmerich, Christopher M / Rusch, Douglas B / Davis, Stephanie D

    Pediatric pulmonology

    2018  Volume 53, Issue 4, Page(s) 475–482

    Abstract: Rationale: Sputum and bronchoalveolar lavage fluid (BALF) are often obtained to elucidate the lower airway microbiota in adults. Acquiring sputum samples from children is difficult and obtaining samples via bronchoscopy in children proves challenging ... ...

    Abstract Rationale: Sputum and bronchoalveolar lavage fluid (BALF) are often obtained to elucidate the lower airway microbiota in adults. Acquiring sputum samples from children is difficult and obtaining samples via bronchoscopy in children proves challenging due to the need for anesthesia and specialized procedural expertise; therefore nasopharyngeal (NP) swabs are often used as surrogates when investigating the pediatric airway microbiota. In adults, the airway microbiota differs significantly between NP and BALF samples however, minimal data exist in children.
    Objectives: To compare NP and BALF samples in children undergoing clinically indicated bronchoscopy.
    Methods: NP and BALF samples were collected during clinically indicated bronchoscopy. Bacterial DNA was extracted from 72 samples (36 NP/BALF pairs); the bacterial V1-V3 region of the 16S rRNA gene was amplified and sequenced on the Illumina Miseq platform. Analysis was performed using mothur software.
    Results: Compared to NP samples, BALF had increased richness and diversity. Similarity between paired NP and BALF (intra-subject) samples was greater than inter-subject samples (P = 0.0006). NP samples contained more Actinobacteria (2.2% vs 21%; adjusted P = 1.4 × 10
    Conclusion: Our results provide evidence that NP samples can be used to distinguish differences between children, but the relative abundance of organisms may differ between the nasopharynx and lower airway in pediatric patients. Studies utilizing NP samples as surrogates for the lower airway should be interpreted with caution.
    MeSH term(s) Adolescent ; Bacteria/classification ; Bacteria/genetics ; Bacteria/isolation & purification ; Bronchoalveolar Lavage Fluid/microbiology ; Bronchoscopy ; Child ; Child, Preschool ; DNA, Bacterial/analysis ; Female ; Humans ; Infant ; Male ; Microbiota/genetics ; Nasopharynx/microbiology ; RNA, Ribosomal, 16S/analysis
    Chemical Substances DNA, Bacterial ; RNA, Ribosomal, 16S
    Language English
    Publishing date 2018-02-06
    Publishing country United States
    Document type Comparative Study ; Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 632784-9
    ISSN 1099-0496 ; 8755-6863
    ISSN (online) 1099-0496
    ISSN 8755-6863
    DOI 10.1002/ppul.23953
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Effectiveness of interventions to improve drinking water, sanitation, and handwashing with soap on risk of diarrhoeal disease in children in low-income and middle-income settings: a systematic review and meta-analysis.

    Wolf, Jennyfer / Hubbard, Sydney / Brauer, Michael / Ambelu, Argaw / Arnold, Benjamin F / Bain, Robert / Bauza, Valerie / Brown, Joe / Caruso, Bethany A / Clasen, Thomas / Colford, John M / Freeman, Matthew C / Gordon, Bruce / Johnston, Richard B / Mertens, Andrew / Prüss-Ustün, Annette / Ross, Ian / Stanaway, Jeffrey / Zhao, Jeff T /
    Cumming, Oliver / Boisson, Sophie

    Lancet (London, England)

    2022  Volume 400, Issue 10345, Page(s) 48–59

    Abstract: Background: Estimates of the effectiveness of water, sanitation, and hygiene (WASH) interventions that provide high levels of service on childhood diarrhoea are scarce. We aimed to provide up-to-date estimates on the burden of disease attributable to ... ...

    Abstract Background: Estimates of the effectiveness of water, sanitation, and hygiene (WASH) interventions that provide high levels of service on childhood diarrhoea are scarce. We aimed to provide up-to-date estimates on the burden of disease attributable to WASH and on the effects of different types of WASH interventions on childhood diarrhoea in low-income and middle-income countries (LMICs).
    Methods: In this systematic review and meta-analysis, we updated previous reviews following their search strategy by searching MEDLINE, Embase, Scopus, Cochrane Library, and BIOSIS Citation Index for studies of basic WASH interventions and of WASH interventions providing a high level of service, published between Jan 1, 2016, and May 25, 2021. We included randomised and non-randomised controlled trials conducted at household or community level that matched exposure categories of the so-called service ladder approach of the Sustainable Development Goal (SDG) for WASH. Two reviewers independently extracted study-level data and assessed risk of bias using a modified Newcastle-Ottawa Scale and certainty of evidence using a modified Grading of Recommendations, Assessment, Development, and Evaluation approach. We analysed extracted relative risks (RRs) and 95% CIs using random-effects meta-analyses and meta-regression models. This study is registered with PROSPERO, CRD42016043164.
    Findings: 19 837 records were identified from the search, of which 124 studies were included, providing 83 water (62 616 children), 20 sanitation (40 799 children), and 41 hygiene (98 416 children) comparisons. Compared with untreated water from an unimproved source, risk of diarrhoea was reduced by up to 50% with water treated at point of use (POU): filtration (n=23 studies; RR 0·50 [95% CI 0·41-0·60]), solar treatment (n=13; 0·63 [0·50-0·80]), and chlorination (n=25; 0·66 [0·56-0·77]). Compared with an unimproved source, provision of an improved drinking water supply on premises with higher water quality reduced diarrhoea risk by 52% (n=2; 0·48 [0·26-0·87]). Overall, sanitation interventions reduced diarrhoea risk by 24% (0·76 [0·61-0·94]). Compared with unimproved sanitation, providing sewer connection reduced diarrhoea risk by 47% (n=5; 0·53 [0·30-0·93]). Promotion of handwashing with soap reduced diarrhoea risk by 30% (0·70 [0·64-0·76]).
    Interpretation: WASH interventions reduced risk of diarrhoea in children in LMICs. Interventions supplying either water filtered at POU, higher water quality from an improved source on premises, or basic sanitation services with sewer connection were associated with increased reductions. Our results support higher service levels called for under SDG 6. Notably, no studies evaluated interventions that delivered access to safely managed WASH services, the level of service to which universal coverage by 2030 is committed under the SDG.
    Funding: WHO, Foreign, Commonwealth & Development Office, and National Institute of Environmental Health Sciences.
    MeSH term(s) Child ; Diarrhea/epidemiology ; Diarrhea/prevention & control ; Drinking Water ; Hand Disinfection ; Humans ; Sanitation ; Soaps
    Chemical Substances Drinking Water ; Soaps
    Language English
    Publishing date 2022-06-28
    Publishing country England
    Document type Journal Article ; Meta-Analysis ; Systematic Review
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(22)00937-0
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: COVID-SAFER: Deprescribing Guidance for Hydroxychloroquine Drug Interactions in Older Adults.

    Ross, Sydney B / Wilson, Marnie Goodwin / Papillon-Ferland, Louise / Elsayed, Sarah / Wu, Peter E / Battu, Kiran / Porter, Sandra / Rashidi, Babak / Tamblyn, Robyn / Pilote, Louise / Downar, James / Bonnici, Andre / Huang, Allen / Lee, Todd C / McDonald, Emily G

    Journal of the American Geriatrics Society

    2020  Volume 68, Issue 8, Page(s) 1636–1646

    Abstract: Background/objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes high morbidity and mortality in older adults with chronic illnesses. Several trials are currently underway evaluating the antimalarial drug ... ...

    Abstract Background/objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes high morbidity and mortality in older adults with chronic illnesses. Several trials are currently underway evaluating the antimalarial drug hydroxychloroquine as a potential treatment for acute infection. However, polypharmacy predisposes patients to increased risk of drug-drug interactions with hydroxychloroquine and may render many in this population ineligible to participate in trials. We aimed to quantify the degree of polypharmacy and burden of potentially inappropriate medications (PIMs) that older hospitalized adults are taking that would interact with hydroxychloroquine.
    Methods: We reanalyzed data from the cohort of patients 65 years and older enrolled in the MedSafer pilot study. We first identified patients taking medications with potentially harmful drug-drug interactions with hydroxychloroquine that might exclude them from participation in a typical 2019 coronavirus disease (COVID-19) therapeutic trial. Next, we identified medications that were flagged by MedSafer as potentially inappropriate and crafted guidance around medication management if contemplating the use of hydroxychloroquine.
    Results: The cohort contained a total of 1,001 unique patients with complete data on their home medications at admission. Of these 1,001 patients, 590 (58.9%) were receiving one or more home medications that could potentially interact with hydroxychloroquine, and of these, 255 (43.2%) were flagged as potentially inappropriate by the MedSafer tool. Common classes of PIMs observed were antipsychotics, cardiac medications, and antidiabetic agents.
    Conclusion: The COVID-19 pandemic highlights the importance of medication optimization and deprescribing PIMs in older adults. By acting now to reduce polypharmacy and use of PIMs, we can better prepare this vulnerable population for inclusion in trials and, if substantiated, pharmacologic treatment or prevention of COVID-19. J Am Geriatr Soc 68:1636-1646, 2020.
    MeSH term(s) Aged ; Aged, 80 and over ; Betacoronavirus ; COVID-19 ; Clinical Trials as Topic ; Coronavirus Infections/drug therapy ; Deprescriptions ; Female ; Humans ; Hydroxychloroquine/administration & dosage ; Male ; Pandemics ; Patient Selection ; Pilot Projects ; Pneumonia, Viral/drug therapy ; Polypharmacy ; Potentially Inappropriate Medication List/standards ; SARS-CoV-2
    Chemical Substances Hydroxychloroquine (4QWG6N8QKH)
    Keywords covid19
    Language English
    Publishing date 2020-06-30
    Publishing country United States
    Document type Journal Article
    ZDB-ID 80363-7
    ISSN 1532-5415 ; 0002-8614
    ISSN (online) 1532-5415
    ISSN 0002-8614
    DOI 10.1111/jgs.16623
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Book ; Online: GymFG

    Wood, Andrew / Sydney, Ali / Chin, Peter / Thapa, Bishal / Ross, Ryan

    A Framework with a Gym Interface for FlightGear

    2020  

    Abstract: Over the past decades, progress in deployable autonomous flight systems has slowly stagnated. This is reflected in today's production air-crafts, where pilots only enable simple physics-based systems such as autopilot for takeoff, landing, navigation, ... ...

    Abstract Over the past decades, progress in deployable autonomous flight systems has slowly stagnated. This is reflected in today's production air-crafts, where pilots only enable simple physics-based systems such as autopilot for takeoff, landing, navigation, and terrain/traffic avoidance. Evidently, autonomy has not gained the trust of the community where higher problem complexity and cognitive workload are required. To address trust, we must revisit the process for developing autonomous capabilities: modeling and simulation. Given the prohibitive costs for live tests, we need to prototype and evaluate autonomous aerial agents in a high fidelity flight simulator with autonomous learning capabilities applicable to flight systems: such a open-source development platform is not available. As a result, we have developed GymFG: GymFG couples and extends a high fidelity, open-source flight simulator and a robust agent learning framework to facilitate learning of more complex tasks. Furthermore, we have demonstrated the use of GymFG to train an autonomous aerial agent using Imitation Learning. With GymFG, we can now deploy innovative ideas to address complex problems and build the trust necessary to move prototypes to the real-world.
    Keywords Computer Science - Artificial Intelligence ; Computer Science - Multiagent Systems ; Computer Science - Robotics ; I.2.1 ; I.6.5
    Subject code 629
    Publishing date 2020-04-26
    Publishing country us
    Document type Book ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

To top